Dr. Zhang Junting is an internationally acclaimed neurosurgeon specializing in brainstem and skull base tumors. With over 30 years of surgical expertise, he has performed over 1,000 complex brainstem tumor surgeries and pioneered minimally invasive approaches for skull base tumors. He is a professor, chief neurosurgeon, and PhD supervisor, holding leadership roles in China’s top neurosurgical associations.
Dr. Zhang Junting is one of Asia’s most respected neurosurgeons, specializing in complex brainstem tumors, skull base tumors, and spinal cord tumor surgeries. He has performed thousands of neurosurgical procedures, refining techniques that improve patient outcomes while minimizing complications.
Dr. Zhang pioneered innovative surgical approaches, including:
Anterior transpetrosal approach for parasellar and cavernous sinus tumors
Retro-sigmoid approach for petroclival tumors
Extended bifrontal approach for clival and sphenoid tumors
His groundbreaking work has contributed to China’s national scientific research projects, including the National 863 Program, 12th Five-Year National Science Support Plan, and 973 Program. He has authored over 200 scientific papers and co-authored major textbooks such as Neurosurgery and Intracranial Tumor Surgery.
Dr. Zhang is also a prominent educator and researcher, serving as:
Vice Chairman of the Chinese Neurosurgery Association
Chairman of the Beijing Neurosurgery Association
Chairman of the Neurosurgery Branch of the Chinese Medical Promotion Association
Member of the 11th and 12th Beijing Municipal Committee of the Chinese People's Political Consultative Conference (CPPCC)
For his contributions to medical science and neurosurgery, he has been recognized with numerous national awards, including:
National May 1st Labor Medal (2004)
Beijing Labor Medal (2004)
Capital’s Top 10 Health Guardians Award (2009)
National Advanced Worker Award (2010)
Dr. Zhang continues to push the boundaries of neurosurgery, using advanced microscopic, minimally invasive, and skull base surgical techniques to treat some of the most challenging brain and spinal tumors.
